| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |